normalized_title,count,object_id,pmid,year,journal,title infectious diseases,2,CPD-0008,8846554,1995,Baillieres Clin Obstet Gynaecol,Infectious diseases. infectious diseases,2,CPD-0016,7838014,1995,Med J Aust,Infectious diseases. which clinical decisions benefit from automation a task complexity approach,2,CPD-0207,15460772,2002,Stud Health Technol Inform,Which clinical decisions benefit from automation? A task complexity approach. which clinical decisions benefit from automation a task complexity approach,2,CPD-0245,12909183,2003,Int J Med Inform,Which clinical decisions benefit from automation? A task complexity approach. antibiotics for ureaplasma in the vagina in pregnancy,2,CPD-0273,14974036,2004,Cochrane Database Syst Rev,Antibiotics for ureaplasma in the vagina in pregnancy. antibiotics for ureaplasma in the vagina in pregnancy,2,CPD-0762,21901685,2011,Cochrane Database Syst Rev,Antibiotics for ureaplasma in the vagina in pregnancy. assignment of reca reference sequence types for enhanced identification of the burkholderia cepacia complex,2,CPD-0808,28193343,2012,Pathology,Assignment of recA reference sequence types for enhanced identification of the Burkholderia cepacia complex. assignment of reca reference sequence types for enhanced identification of the burkholderia cepacia complex,2,CPD-0809,22565325,2012,Pathology,Assignment of recA reference sequence types for enhanced identification of the Burkholderia cepacia complex. one moment doctor have you forgotten hand hygiene,2,CPD-0950,24835700,2014,Med J Aust,One moment doctor! Have you forgotten hand hygiene? one moment doctor have you forgotten hand hygiene,2,CPD-0951,25163373,2014,Med J Aust,One moment doctor! Have you forgotten hand hygiene? pulmonary cryptococcosis,2,CPD-1018,26398535,2015,Semin Respir Crit Care Med,Pulmonary Cryptococcosis. pulmonary cryptococcosis,2,CPD-1796,36354923,2022,J Fungi (Basel),Pulmonary Cryptococcosis. knowing when to stop antibiotic therapy,2,CPD-1037,26068682,2015,Med J Aust,Knowing when to stop antibiotic therapy. knowing when to stop antibiotic therapy,2,CPD-1038,25669463,2015,Med J Aust,Knowing when to stop antibiotic therapy. changing epidemiology of candidaemia in australia,2,CPD-1221,28364558,2017,J Antimicrob Chemother,Changing epidemiology of candidaemia in Australia. changing epidemiology of candidaemia in australia,2,CPD-1222,28204502,2017,J Antimicrob Chemother,Changing epidemiology of candidaemia in Australia. global disparities in sars cov 2 genomic surveillance,2,CPD-1638,34462754,2021,medRxiv [Preprint],Global disparities in SARS-CoV-2 genomic surveillance. global disparities in sars cov 2 genomic surveillance,2,CPD-1761,36385137,2022,Nat Commun,Global disparities in SARS-CoV-2 genomic surveillance. a shared pathogenic mechanism for valproic acid and shroom3 knockout in a brain organoid model of neural tube defects,2,CPD-1953,37443734,2023,Cells,A Shared Pathogenic Mechanism for Valproic Acid and SHROOM3 Knockout in a Brain Organoid Model of Neural Tube Defects. a shared pathogenic mechanism for valproic acid and shroom3 knockout in a brain organoid model of neural tube defects,2,CPD-1954,37090564,2023,bioRxiv [Preprint],A Shared Pathogenic Mechanism for Valproic Acid and SHROOM3 Knockout in a Brain Organoid Model of Neural Tube Defects. bioorthogonal cyclopropenones for investigating rna structure,2,CPD-1990,39641920,2024,ACS Chem Biol,Bioorthogonal Cyclopropenones for Investigating RNA Structure. bioorthogonal cyclopropenones for investigating rna structure,2,CPD-1991,39484557,2024,bioRxiv [Preprint],Bioorthogonal cyclopropenones for investigating RNA structure. delayed forebrain excitatory and inhibitory neurogenesis in strada related megalencephaly via mtor hyperactivity,2,CPD-2118,40462897,2025,bioRxiv [Preprint],Delayed forebrain excitatory and inhibitory neurogenesis in STRADA-related megalencephaly via mTOR hyperactivity. delayed forebrain excitatory and inhibitory neurogenesis in strada related megalencephaly via mtor hyperactivity,2,CPD-2200,41791387,2026,Stem Cell Reports,Delayed forebrain excitatory and inhibitory neurogenesis in STRADA-related megalencephaly via mTOR hyperactivity.